Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 12, 2019 at 03:04 pm
Share
Easywell Biomedicals, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 80.278 million compared to TWD 94.620 million a year ago. Operating loss was TWD 49.979 million compared to TWD 40.441 million a year ago. Net loss was TWD 51.670 million compared to TWD 34.232 million a year ago. Basic loss per share from continuing operations was TWD 0.46 compared to TWD 0.29 a year ago. Basic loss per share was TWD 0.47 compared to TWD 0.35 a year ago. For the nine months, sales was TWD 271.539 million compared to TWD 270.574 million a year ago. Operating loss was TWD 162.048 million compared to TWD 150.858 million a year ago. Net loss was TWD 180.560 million compared to TWD 150.537 million a year ago. Basic loss per share from continuing operations was TWD 1.54 compared to TWD 1.34 a year ago. Basic loss per share was TWD 1.68 compared to TWD 1.52 a year ago.
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.
EASYWELL BIOMEDICALS, INC. 